NEW YORK (GenomeWeb) – DNA chip developer Centrillion Technologies said today that it has received a multimillion US dollar investment from medical and healthcare solutions firm WeDoctor of China as part of a strategic partnership. Separately, Centrillion Technologies Taiwan said it has received a strategic investment of an undisclosed amount from the Arm IoT Fund.

Palo Alto, California-based Centrillion also recently raised at least $56 million in private placements, according to documents filed  with the US Securities and Exchange Commission last month.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.

Oct
25
Sponsored by
Roche

This webinar will detail a comprehensive strategy that a lab has put in place to evaluate  NGS oncology assays for genomic tumor profiling of plasma and tissue samples.